Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%
- Conditions
- Development
- Interventions
- Drug: Formula or breast milkDrug: multiple doses of sucrose
- Registration Number
- NCT01742520
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
The purpose of this study is to determine the effect of sucrose 24% for pain prevention on preterm infants. Our hypothesis is that repeated doses of sucrose 24%, given prior to painful procedure,do not impair neurodevelopmental outcomes of preterm infants
- Detailed Description
preterm infants born at 27-33 weeks gestational age at Sheba Medical Center will be recruited for this study. Prior to invasive procedure infants will be treated with pacifier and swaddling as recommended by the American Academy of Pediatrics and Canadian Pediatric Society.
Group 1.Will be treated with Sucrose 24% 0.1-0.5ml on the anterior pat of the tongue 1-3 min prior to invasive procedure.
Group 2. Similar to group 1 but breast milk or formula will replace Sucrose.
Number of invasive procedures/day will be documented
General Movements by Prechtel will be used for developmental assessment at 2,4,6 weeks after birth and at 14-16 weeks corrected age
Griffiths developmental scales (GMDS) will be used at 40 weeks, 14-16 weeks corrected age, and 3-6 month corrected age
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 90
- preterm infants born at SMC
- need for intubation
- surgery
- need for sedation
- abnormal head ultrasound
- genetic abnormalities
- necrotizing enterocolitis
- other painful conditions other than routine blood exams
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Formula or Breast Milk Formula or breast milk Breast milk or formula prior to every painful procedure. Multiple doses of sucrose multiple doses of sucrose Infants in this group will be treated with Sucrose 24% 0.5-1ml on the anterior pat of the tongue 1-3min prior to every invasive procedure
- Primary Outcome Measures
Name Time Method neurodevelopmental outcomes at 6 month corrected age Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel
- Secondary Outcome Measures
Name Time Method neurodevelopment at 15 weeks corrected age Griffith mental developmental scaled (gross and fine motor, language, performance, social) and General movements by Prechtel
Trial Locations
- Locations (1)
Sheba Medical Center
🇮🇱Ramat Gan, Israel